Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Iva Selke Krulichová"'
Autor:
Ondřej Kubeček, Jan Laco, Jiří Špaček, Alena Kubečková, Jiří Petera, Iva Selke Krulichová, Aleš Bezrouk, Stanislav Filip, Jindřich Kopecký
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 2914-2927 (2021)
Background: Secondary tumors of the ovary (STOs) account for 10–25% of all ovarian malignancies, including metastases from primary gynecological tumors. Colorectal cancer (CRC) has been recognized as one of the most common causes of STOs in Western
Externí odkaz:
https://doaj.org/article/624e3aa44f564ab48754237d1a22b50b
Autor:
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell, Bjorn Wettermark
Publikováno v:
BioMed Research International. 2023:1-3
Autor:
Iva Selke Krulichová, Gisbert W. Selke, Marion Bennie, Mohammadhossein Hajiebrahimi, Fredrik Nyberg, Jurij Fürst, Kristina Garuolienė, Elisabetta Poluzzi, Juraj Slabý, Corinne Zara Yahni, Mattia Altini, Maria Pia Fantini, Václav Kočí, Stuart McTaggart, Caridad Pontes, Chiara Reno, Simona Rosa, Marta Turu Pedrola, Mitja Udovič, Björn Wettermark
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:1046-1055
The COVID-19 pandemic had an impact on health care, with disruption to routine clinical care. Our aim was to describe changes in prescription drugs dispensing in the primary and outpatient sectors during the first year of the pandemic across Europe.W
Autor:
Petr Kelbich, Tomáš Radovnický, Iva Selke-Krulichová, Jan Lodin, Inka Matuchová, Martin Sameš, Jan Procházka, Jan Krejsek, Eva Hanuljaková, Aleš Hejčl
Publikováno v:
Brain Sciences, Vol 10, Iss 10, p 698 (2020)
Brain ischemia after central nervous system (CNS) bleeding significantly influences the final outcome of patients. Catalytic activities of aspartate aminotransferase (AST) in the cerebrospinal fluid (CSF) to detect brain ischemia were determined in t
Externí odkaz:
https://doaj.org/article/da3f0bebab424c58980656c7fa38295d
Publikováno v:
European Journal of Clinical Pharmacology. 77:1553-1561
The aim of this study was to explore patterns and long-term development in prescribing potentially inappropriate medication (PIM) according to the EU(7)-PIM list to elderly patients in Germany. We analysed anonymized German claims data. The study pop
Autor:
Mikael Hoffmann, Stuart McTaggart, Vanda Marković-Peković, Irene Langner, Skule Ingeberg, Iva Selke Krulichová, Carol Holmes, Juraj Slabý, Brian Godman, Biljana Tubić, Svens Henkuzens, Corinne Zara, Jakub Rutkowski, Jurij Fürst, András Inotai, Stephen Campbell, Konstantin Tachkov, Sean MacBride-Stewart, Ileana Mardare, Mihajlo Jakovljevic, Kristina Garuolienė, Marta Turu Pedrola, Øyvind Melien, Gisbert Selke, Magdalene Wladysiuk, Björn Wettermark, Amanj Kurdi, Arianit Jakupi, Caridad Pontes, Vasileios Kourafalos, Manfred Hinteregger, Eleonora Allocati, Radka Nejezchlebova, Guenka Petrova, Francis Kalemeera, Rita Banzi, András Harsányi, Patricia Vella Bonanno, Ott Laius, Robert Sauermann, Alice Pisana, Jolanta Gulbinovič, Anna Nachtnebel, Iris Hoxha
Publikováno v:
BioMed research international, London : Hindawi Ltd., 2021, vol. 2021, art. no. 9996193, p. [1-16]
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International, Vol 2021 (2021)
Background. Diabetes mellitus rates and associated costs continue to rise across Europe enhancing health authority focus on its management. The risk of complications is enhanced by poor glycaemic control, with long-acting insulin analogues developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f71eb049d04b088f4f63846e1ca06c
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
Publikováno v:
European journal of clinical pharmacology. 77(10)
The aim of this study was to explore patterns and long-term development in prescribing potentially inappropriate medication (PIM) according to the EU(7)-PIM list to elderly patients in Germany.We analysed anonymized German claims data. The study popu
Autor:
Wouter Hamelinck, Elita Poplavska, Ott Laius, Ruaraidh Hill, Jurij Fürst, Dzintars Gotham, Iva Selke Krulichová, Zornitza Mitkova, Ileana Mardare, Andrew F. Hill, Stuart McTaggart, Brian Godman, Corrine Zara, Vanda Marković-Peković, Patricia Vella Bonanno, Mark Parker, Caridad Pontes, Katarina Banasova, Tanja Novakovic, John Yfantopoulos, Janet Wale, Irene Langner, Hans Piepenbrink, Christian Hierländer, Peter Skiold, Guenka Petrova, Magdalene Wladysiuk, Amanj Kurdi, Vincent de Valk, Stephen Campbell, Anna Nachtnebel, Admir Malaj, Roberta Joppi, Angela Timoney, Maria Juhasz-Haverinen, Antony P. Martin, Jolanta Gulbinovič, Merce Obach Cortadellas, Iris Hoxha, Arianit Jakupi, Durhane Wong-Rieger, Catherine Sermet, D Tomek, Gisbert Selke, Eleonora Allocati, Ieva Greiciute-Kuprijanov, Tomasz Bochenek, Steven Simoens, Robert Plisko
Publikováno v:
University of Strathclyde
Introduction/Objectives: Health authorities are facing increasing challenges to the sustainability of their healthcare systems because of the growing expenditures on medicines, including new, high-priced oncology medicines, and changes in disease pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77151d4ac5e7399df29d92a7faac2a6
https://strathprints.strath.ac.uk/75033/1/Godman_etal_GABI_2021_Variation_in_the_prices_of_oncology_medicines_across_Europe.pdf
https://strathprints.strath.ac.uk/75033/1/Godman_etal_GABI_2021_Variation_in_the_prices_of_oncology_medicines_across_Europe.pdf
Autor:
Ruaraidh Hill, Christian Hierländer, Carolina Zampirolli Dias, Tomasz Bochenek, Ott Laius, Lars L. Gustafsson, Tracey-Lea Laba, Arianit Jakupi, Øyvind Melien, Wija Oortwijn, Luka Voncina, Durhane Wong-Rieger, Caridad Pontes, Jf Hans Piepenbrink, Magdalene Wladysiuk, Guenka Petrova, Patricia Vella Bonanno, Corinne Zara, Robert Sauermann, Steven Simoens, Olayinka O Ogunleye, Amanj Kurdi, Wouter Hamelinck, Wania Cristina Silva, Dzintars Gotham, Seung Jin Bae, Johanna C Meyer, Roberta Joppi, Janet Wale, Admir Malaj, John Yfantopoulos, Gisbert Selke, Angela Timoney, Brian Godman, Vincent de Valk, Andrew Hill, Merce Obach Cortadellas, D Tomek, Hye-Young Kwon, Irene Langner, Jurij Fürst, Iva Selke Krulichová, Antony P. Martin, Jolanta Gulbinovič, Iris Hoxha, Eleonora Allocati, Stuart McTaggart, Ieva Greiciute-Kuprijanov, Vanda Marković-Peković, Ileana Mardare
Publikováno v:
Expert review of pharmacoeconomics and outcomes research, Abingdon : Taylor and Francis Ltd., 2021, vol. 21, iss. 4, p. 527-540
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 527-540
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 4, pp. 527-540
Expert review of pharmacoeconomics & outcomes research
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 527-540
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 4, pp. 527-540
Expert review of pharmacoeconomics & outcomes research
Introduction: There are growing concerns among European health authorities regarding increasing prices for new cancer medicines, prices not necessarily linked to health gain and the implications for the sustainability of their healthcare systems. Are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfe77330e4296c7333cde6b78e19b86
https://repository.vu.lt/VU:ELABAPDB88291411&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB88291411&prefLang=en_US
Autor:
Brian Godman, Veronika Lappe, Iva Selke Krulichová, Ingrid Schubert, Uwe Eichler, Gisbert Selke
Publikováno v:
CURRENT MEDICAL RESEARCH AND OPINION
Objective: Combined hormonal contraceptives (CHC) exhibit differing risks for cardiovascular and thrombotic events (VTE). A European referral process confirmed higher VTE risks for 3 rd generation gestagens and drospirenone. CHC are now grouped in ri